The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
Open accessAbstract
INTRODUCTION: Europe is an important focus for compiling accurate and up-to-date world cancer statistics owing to its large share of the world's total cancer burden. This article presents incidence and mortality estimates for 25 major cancers across 40 individual countries within European areas and the European Union (EU-27) for the year 2020. METHODS: The estimated national incidence and mortality rates are based on statistical methodology previously applied and verified using the most recently collected incidence data from 151 population-based cancer registries, mortality data and 2020 population estimates. RESULTS: Estimates reveal 4 million new cases of cancer (excluding non-melanoma skin cancer) and 1.9 million cancer-related deaths. The most common cancers are: breast in women (530,000 cases), colorectum (520,000), lung (480,000) and prostate (470,000). These four cancers account for half the overall cancer burden in Europe. The most common causes of cancer deaths are: lung (380,000), colorectal (250,000), breast (140,000) and pancreatic (130,000) cancers. In EU-27, the estimated new cancer cases are approximately 1.4 million in males and 1.2 million in females, with over 710,000 estimated cancer deaths in males and 560,000 in females. CONCLUSION: The 2020 estimates provide a basis for establishing priorities in cancer-control measures across Europe. The long-established role of cancer registries in cancer surveillance and the evaluation of cancer control measures remain fundamental in formulating and adapting national cancer plans and pan-European health policies. Given the estimates are built on recorded data prior to the onset of coronavirus disease 2019 (COVID-19), they do not take into account the impact of the pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationHarrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
Self-citationEstimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
Self-citationFerlay, J., Colombet, M., Soerjomataram, I., Dyba, T., Randi, G., Bettio, M., Gavin, A., Visser, O., & Bray, F. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.07.005 · Cited by 2,478
Self-citationEstimates of cancer incidence and mortality in Europe in 2008
Ferlay, J., Parkin, D. M., & Steliarova-Foucher, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.014 · Cited by 2,319
Self-citationDe Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70546-1 · Cited by 1,890
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F., & Jemal, A. (2020) · European Urology · doi:10.1016/j.eururo.2019.08.005 · Cited by 1,364
Self-citationShibuya, K., Ciecierski, C., Guindon, E., Bettcher, D. W., Evans, D. B., & Murray, C. J. L. (2003) · BMJ · doi:10.1136/bmj.327.7407.154 · Cited by 1,239
Cancer incidence and mortality in Europe, 2004
Boyle, P., & Ferlay, J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi098 · Cited by 1,217
Self-citationFewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
Dinmohamed, A. G., Visser, O., Verhoeven, R. H. A., Louwman, M. W. J., van Nederveen, F. H., Willems, S. M., Merkx, M. A. W., Lemmens, V. E. P. P., Nagtegaal, I. D., & Siesling, S. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30265-5 · Cited by 699
Estimates of cancer incidence and mortality in Europe in 1995
Bray, F., Sankila, R., Ferlay, J., & Parkin, D. M. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00350-1 · Cited by 686
Self-citationPourshams, A., Sepanlou, S. G., Ikuta, K. S., Bisignano, C., Safiri, S., Roshandel, G., Sharif, M., Khatibian, M., Fitzmaurice, C., Nixon, M. R., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30347-4 · Cited by 658
Kamangar, F., Nasrollahzadeh, D., Safiri, S., Sepanlou, S. G., Fitzmaurice, C., Ikuta, K. S., Bisignano, C., Islami, F., Roshandel, G., Lim, S. S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30007-8 · Cited by 641
Brown, K. F., Rumgay, H., Dunlop, C., Ryan, M., Quartly, F., Cox, A., Deas, A., Elliss-Brookes, L., Gavin, A., Hounsome, L., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0029-6 · Cited by 557
Self-citationArnold, M., Karim-Kos, H. E., Coebergh, J. W., Byrnes, G., Antilla, A., Ferlay, J., Renehan, A. G., Forman, D., & Soerjomataram, I. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.002 · Cited by 513
Self-citationCancer in the European community and its member states
Møller Jensen, O., Estève, J., Møller, H., & Renard, H. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90278-2 · Cited by 455
The IARC Perspective on Colorectal Cancer Screening
Lauby-Secretan, B., Vilahur, N., Bianchini, F., Guha, N., & Straif, K. (2018) · New England Journal of Medicine · doi:10.1056/nejmsr1714643 · Cited by 352
The cost of cancer in Europe 2018
Hofmarcher, T., Lindgren, P., Wilking, N., & Jönsson, B. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.01.011 · Cited by 327
Prostate cancer incidence and mortality trends in 37 European countries: An overview
Bray, F., Lortet-Tieulent, J., Ferlay, J., Forman, D., & Auvinen, A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.013 · Cited by 307
Self-citationTrends and predictions to 2020 in breast cancer mortality in Europe
Carioli, G., Malvezzi, M., Rodriguez, T., Bertuccio, P., Negri, E., & La Vecchia, C. (2017) · The Breast · doi:10.1016/j.breast.2017.06.003 · Cited by 264
Lortet-Tieulent, J., Renteria, E., Sharp, L., Weiderpass, E., Comber, H., Baas, P., Bray, F., Coebergh, J. W., & Soerjomataram, I. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2013.10.014 · Cited by 186
Self-citationEuropean cancer mortality predictions for the year 2020 with a focus on prostate cancer
Carioli, G., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., Negri, E., & Malvezzi, M. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.009 · Cited by 171
Carioli, G., Malvezzi, M., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., & Negri, E. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.01.006 · Cited by 168
Bray, F. I., & Weiderpass, E. (2010) · International Journal of Cancer · doi:10.1002/ijc.24855 · Cited by 167
Self-citationFamily History of Colorectal Adenomatous Polyps and Increased Risk for Colorectal Cancer
Ahsan, H., Neugut, A. I., Garbowski, G. C., Jacobson, J. S., Forde, K. A., Treat, M. R., & Waye, J. D. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00006 · Cited by 158
An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence
Antoni, S., Soerjomataram, I., Møller, B., Bray, F., & Ferlay, J. (2016) · Bulletin of the World Health Organization · doi:10.2471/blt.15.164384 · Cited by 119
Self-citationLoos, A. H., Bray, F., McCarron, P. A., Weiderpass, E., Hakama, M., & Parkin, D. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.09.007 · Cited by 92
Self-citationImpact of COVID-19 on cancer diagnosis and management in Slovenia – preliminary results
Zadnik, V., Mihor, A., Tomšič, S., Žagar, T., Bric, N., Lokar, K., & Oblak, I. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0048 · Cited by 88
The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998–2012
Maso, L. D., Panato, C., Franceschi, S., Serraino, D., Buzzoni, C., Busco, S., Ferretti, S., Torrisi, A. A. M., Falcini, F., Zorzi, M., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.01.083 · Cited by 86
Precision of incidence predictions based on poisson distributed observations
Hakulinen, T. R., & Dyba, T. A. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131503 · Cited by 83
Self-citationExcess of cancers in Europe: A study of eleven major cancers amenable to lifestyle change
Soerjomataram, I., de Vries, E., Pukkala, ., & Coebergh, J. W. W. (2006) · International Journal of Cancer · doi:10.1002/ijc.22459 · Cited by 80
Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark
Skovlund, C. W., Friis, S., Dehlendorff, C., Nilbert, M. C., & Mørch, L. S. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1858235 · Cited by 75
Coebergh, J. W. W., van den Hurk, C. J. G., Rosso, S., Comber, H., Storm, H. H., Zanetti, R., Sacchetto, L., Janssen-Heijnen, M. L. G., Thong, M. S. Y., Siesling, S., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.02.018 · Cited by 40
Scrutiny-Dependent Cancer and Self-fulfilling Risk Factors
Welch, H. G., & Brawley, O. W. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2792 · Cited by 37
Kvåle, R., Myklebust, T. Å., Engholm, G., Heinävaara, S. H., Wist, E., & Møller, B. (2017) · International Journal of Cancer · doi:10.1002/ijc.30924 · Cited by 36
Neamţiu, L., Martos, C., Giusti, F., Negrão Carvalho, R., Randi, G., Dimitrova, N., Flego, M., Dyba, T., Bettio, M., Gavin, A., et al. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckab214 · Cited by 28
Self-citationCrocetti, E., Dyba, T., Martos, C., Randi, G., Rooney, R. M., & Bettio, M. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000250 · Cited by 20
Self-citationThe Impact of the COVID-19 Pandemic on Barrett’s Esophagus and Esophagogastric Cancer
Turkington, R. C., Lavery, A., Donnelly, D. W., Cairnduff, V., McManus, D. T., & Coleman, H. G. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.208 · Cited by 20
Engels, E. (2000) · doi:10.1002/1097-0258(20000715)19:13 · Cited by 2
Cited by
Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
Quílez, C., Bebiano, L. B., Jones, E., Maver, U., Meesters, L., Parzymies, P., Petiot, E., Rikken, G., Risueño, I., Zaidi, H., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.032 · Cited by 65
Neamţiu, L., Martos, C., Giusti, F., Negrão Carvalho, R., Randi, G., Dimitrova, N., Flego, M., Dyba, T., Bettio, M., Gavin, A., et al. (2022) · European Journal of Public Health · doi:10.1093/eurpub/ckab214 · Cited by 28
Self-citation
Metadata
- Authors
- Dyba, T., Randi, G., Bray, F., Martos, C., Giusti, F., Nicholson, N., Gavin, A., Flego, M., Neamtiu, L., Dimitrova, N., Negrão Carvalho, R., Ferlay, J., & Bettio, M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 157
- Pages
- 308-347
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W3200667602
- Cited by
- 641
- References
- 42
- FWCI
- 37.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.